Nature Communications (Feb 2023)
Author Correction: ZIP1+ fibroblasts protect lung cancer against chemotherapy via connexin-43 mediated intercellular Zn2+ transfer
- Chen Ni,
- Xiaohan Lou,
- Xiaohan Yao,
- Linlin Wang,
- Jiajia Wan,
- Xixi Duan,
- Jialu Liang,
- Kaili Zhang,
- Yuanyuan Yang,
- Li Zhang,
- Chanjun Sun,
- Zhenzhen Li,
- Ming Wang,
- Linyu Zhu,
- Dekang Lv,
- Zhihai Qin
Affiliations
- Chen Ni
- Medical Research Center, the First Affiliated Hospital of Zhengzhou University
- Xiaohan Lou
- Medical Research Center, the First Affiliated Hospital of Zhengzhou University
- Xiaohan Yao
- Medical Research Center, the First Affiliated Hospital of Zhengzhou University
- Linlin Wang
- Medical Research Center, the First Affiliated Hospital of Zhengzhou University
- Jiajia Wan
- Medical Research Center, the First Affiliated Hospital of Zhengzhou University
- Xixi Duan
- Medical Research Center, the First Affiliated Hospital of Zhengzhou University
- Jialu Liang
- Medical Research Center, the First Affiliated Hospital of Zhengzhou University
- Kaili Zhang
- Medical Research Center, the First Affiliated Hospital of Zhengzhou University
- Yuanyuan Yang
- Medical Research Center, the First Affiliated Hospital of Zhengzhou University
- Li Zhang
- Medical Research Center, the First Affiliated Hospital of Zhengzhou University
- Chanjun Sun
- Medical Research Center, the First Affiliated Hospital of Zhengzhou University
- Zhenzhen Li
- Medical Research Center, the First Affiliated Hospital of Zhengzhou University
- Ming Wang
- Medical Research Center, the First Affiliated Hospital of Zhengzhou University
- Linyu Zhu
- Medical Research Center, the First Affiliated Hospital of Zhengzhou University
- Dekang Lv
- Institute of Cancer Stem Cell, Dalian Medical University
- Zhihai Qin
- Medical Research Center, the First Affiliated Hospital of Zhengzhou University
- DOI
- https://doi.org/10.1038/s41467-023-36663-1
- Journal volume & issue
-
Vol. 14,
no. 1
pp. 1 – 1
Abstract
No abstracts available.